A special use of PR: Corporate social responsibility
Bu tez size mi ait?
Bu kayıt toplu arşivden geldi. Sizinse profilinize bağlayın.
Özet (EN)
The aim of this study is to better understand the advent of the corporate social responsibility (CSR) - to diagnose the concept and to evaluate which of the CSR areas are most and less preferred in Turkey. Another aim is to gain insight on a CSR process model as applied by PR agencies or specialists. In the secondary research, literature is reviewed for definitions of CSR, relationship of CSR and public relations and the areas of CSR in both the world and Turkey. In study 1, indepth interviews were conducted, in which the practices of CSR in Turkey were discussed. The interviews have revealed that the most encountered CSR projects are the ones concerning education, then comes the health and environmental issues, next the ones concerning art and culture and lastly human rights and the employee affairs. Study 2 consists of a case study in which TurkcelPs CSR project, "Contemporary Girls of Contemporary Turkey", (the winner in the Golden World Awards for Excellence in Public Relations, 2001) is analyzed. Key words: Public Relations, Social Responsibility, Corporate Social Responsibility, Case Study. VII
Yazar
Pelin Hürmeriç
Bu Yayına Nasıl Atıf Yapılır
Pelin Hürmeriç (Master Thesis). A special use of PR: Corporate social responsibility, 2004, Yeditepe University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- The relationship between mindfulness and sleep quality: The mediating role of smartphone addiction and bedtime procrastination(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)
- Declaration obligation of the insurant during the conclusion of the contract(2021)